EP Patent

EP4582084A4 — Crystalline form of a ketoamide derivative and method for its preparation

Assigned to Guangdong Raynovent Biotech Co Ltd · Expires 2025-12-31 · 0y expired

What this patent protects

Patent listed against Paxlovid (Copackaged).

Drugs covered by this patent

Paxlovid (Copackaged) (Nirmatrelvir) · Pfizer

Patent Metadata

Patent number: EP4582084A4
Jurisdiction: EP
Classification: —
Expires: 2025-12-31
Drug substance claim: No
Drug product claim: No
Assignee: Guangdong Raynovent Biotech Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.